Related Experiment Video
Updated: Aug 22, 2025
Intracranial Injection of Adeno-associated Viral Vectors
Published on: November 17, 2010
Development of microglia-targeting adeno-associated viral vectors as tools to study microglial behavior in vivo
Yukihiro Okada1, Nobutake Hosoi1, Yasunori Matsuzaki1
1Department of Neurophysiology and Neural Repair, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
Abstract:
Here we describe the microglia-targeting adeno-associated viral (AAV) vectors containing a 1.7-kb putative promoter region of microglia/macrophage-specific ionized calcium-binding adaptor molecule 1 (Iba1), along with repeated miRNA target sites for microRNA (miR)-9 and miR-129-2-3p. The 1.7-kb genomic sequence upstream of the start codon in exon 1 of the Iba1 (Aif1) gene, functions as microglia preferential promoter in the striatum and cerebellum. Furthermore, ectopic transgene expression in non-microglial cells is markedly suppressed upon adding two sets of 4-repeated miRNA target sites for miR-9 and miR-129-2-3p, which are expressed exclusively in non-microglial cells and sponged AAV-derived mRNAs. Our vectors transduced ramified microglia in healthy tissues and reactive microglia in lipopolysaccharide-treated mice and a mouse model of neurodegenerative disease. Moreover, live fluorescent imaging allowed the monitoring of microglial motility and intracellular Ca2+ mobilization. Thus, microglia-targeting AAV vectors are valuable for studying microglial pathophysiology and therapies, particularly in the striatum and cerebellum.
Insights
New adeno-associated viral (AAV) vectors specifically target microglia using the Iba1 promoter. These vectors enable precise gene delivery for studying microglial function and disease in the brain.
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Microglia play crucial roles in brain health and disease.
- Targeted delivery of therapeutic agents to microglia is challenging.
- Existing viral vectors lack specificity for microglial cells.
Purpose of the Study:
- To develop novel adeno-associated viral (AAV) vectors for microglia-specific gene delivery.
- To utilize the ionized calcium-binding adaptor molecule 1 (Iba1) promoter for targeted expression.
- To enhance specificity by incorporating microRNA (miRNA) target sites.
Main Methods:
- Construction of AAV vectors with a 1.7-kb Iba1 promoter region.
- Inclusion of repeated miRNA target sites for miR-9 and miR-129-2-3p to suppress off-target expression.
- Testing vector transduction in healthy mice, lipopolysaccharide-treated mice, and a neurodegenerative disease model.
- Utilizing live fluorescent imaging to monitor microglial activity and calcium mobilization.
Main Results:
- The 1.7-kb Iba1 promoter demonstrated preferential activity in microglia within the striatum and cerebellum.
- Ectopic transgene expression in non-microglial cells was significantly reduced by the miRNA target sites.
- Vectors successfully transduced both ramified microglia in healthy tissue and reactive microglia in disease models.
- Live imaging enabled real-time monitoring of microglial motility and intracellular calcium dynamics.
Conclusions:
- Microglia-targeting AAV vectors offer a promising tool for investigating microglial pathophysiology.
- These vectors facilitate the study of neurodegenerative diseases and potential therapeutic interventions.
- The developed vectors show high specificity and efficacy in targeting microglia in the central nervous system, particularly in the striatum and cerebellum.
